This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,336.09, is for the delivery of PYLERA CAPSULE UU 120S medical products. The contract has an ultimate completion date of February 5, 2025 and was awarded on February 4, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $26,481.30 firm fixed-price delivery order is for 4,556,045,141 PYLERA CAPSULE UU 120S, with a completion date of January 25, 2022. The contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This federal contract award, valued at $1,564.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PYLERA CAPSULE UU 120S, a medical commodity. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,506.53 delivery order is for PYLERA CAPSULE UU 120S, a pharmaceutical product, and is priced on a Firm Fixed Price basis. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of PYLERA CAPSULE UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $4,370.88 with a firm fixed price. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 12, 2022 and was awarded on August 11, 2022. This contract is not designated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,627.37 firm fixed-price delivery order is for the supply of Pylera Capsules to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which enables the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately six hundred six dollars and eighteen cents to Amerisourcebergen Drug Corporation for PYLERA capsules. The order is for one hundred twenty capsules to be delivered to a facility in Conshohocken, Pennsylvania by July thirty-first, twenty twenty-three. Amerisourcebergen will fulfill the order as the prime contractor. The Defense Logistics Agency utilizes such contracts and delivery orders to procure...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,451.54, is a delivery order for the supply of Piperacil-Tazobact 3.375 gm vials. The contract has an ultimate completion date of January 2, 2025 and is a firm fixed-price agreement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $105,070.12, is a delivery order for pharmaceutical products and medical supplies. It is a firm fixed-price contract with an ultimate completion date of August 5, 2015. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $13,929.10 with a firm fixed price pricing type and a completion date of January 21, 2025. The contract provides pharmaceutical products, including the ORSERDU 345 MG TABLET 30S, to support military treatment facilities, veterans' healthcare programs, and other federal medical...